Atomo Diagnostics (ASX:AT1) FCF Yield %: -14.59 (As of Jun. 26, 2026)


What is Atomo Diagnostics FCF Yield %?

Atomo Diagnostics ASX:AT1 FCF Yield % is -14.59 as of Jun. 26, 2026. The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Atomo Diagnostics ranks worse than 78.83% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Atomo Diagnostics's Trailing 12-Month Free Cash Flow is A$-2.23 Mil, and Market Cap is A$15.32 Mil. Therefore, Atomo Diagnostics's FCF Yield % for today is -14.59%.

The historical rank and industry rank for Atomo Diagnostics's FCF Yield % or its related term are showing as below:

ASX:AT1' s FCF Yield % Range Over the Past 10 Years
Min: -52.12   Med: -15.77   Max: -4.98
Current: -14.59


During the past 6 years, the highest FCF Yield % of Atomo Diagnostics was -4.98%. The lowest was -52.12%. And the median was -15.77%.

ASX:AT1's FCF Yield % is ranked worse than
78.83% of 855 companies
in the Medical Devices & Instruments industry
Industry Median: -0.38 vs ASX:AT1: -14.59

Atomo Diagnostics's FCF Margin % for the quarter that ended in Dec. 2025 was -47.39%.


Atomo Diagnostics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Atomo Diagnostics FCF Yield % Related Terms


Atomo Diagnostics FCF Yield % Historical Data

* Premium members only.

The historical data trend for Atomo Diagnostics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atomo Diagnostics FCF Yield % Chart

Atomo Diagnostics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Yield %
Get a 7-Day Free Trial -9.62 -15.99 -49.75 -29.42 -19.26

Atomo Diagnostics Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.79 -35.27 -12.65 -23.68 -6.92

ASX:AT1 vs ABT, SYK, MDT: FCF Yield % Comparison

For the Medical Devices subindustry, Atomo Diagnostics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atomo Diagnostics FCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Atomo Diagnostics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Atomo Diagnostics's FCF Yield % falls into.



Atomo Diagnostics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Atomo Diagnostics's FCF Yield % for the fiscal year that ended in Jun. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-1.993 / 10.34761
=-19.26%

Atomo Diagnostics's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.009 * 2 / 29.1663
=-6.92%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -14.59 mean?
Atomo Diagnostics (ASX:AT1) has a FCF Yield % of -14.59 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Atomo Diagnostics and its competitors. According to the industry distribution chart, Atomo Diagnostics ranks #674 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 78.8%.
Is Atomo Diagnostics' FCF Yield % too high?
Atomo Diagnostics' current FCF Yield % is -14.59. Based on the distribution chart, Atomo Diagnostics ranks #674 out of 855 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Atomo Diagnostics' FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Atomo Diagnostics ranks #674 out of 855 companies for FCF Yield %. This places Atomo Diagnostics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Atomo Diagnostics and its competitors. Atomo Diagnostics's current FCF Yield % is -14.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atomo Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Atomo Diagnostics (ASX:AT1) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.02 — trading 15% below its estimated fair value. The current FCF Yield % is -14.59. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Atomo Diagnostics (ASX:AT1), the current FCF Yield % is -14.59 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atomo Diagnostics Business Description

Address 3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.